Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 142 results.
User Information
Export Records
  1. 1.   CRISPR-targeted MAGT1 insertion restores XMEN patient hematopoietic stem cells and lymphocytes
  2. Brault, Julie; Liu, Taylor; Bello, Ezekiel; Liu, Siyuan; Sweeney, Colin L.; Meis, Ronald J.; Koontz, Sherry; Corsino, Cristina; Choi, Uimook; Vayssiere, Guillaume; Bosticardo, Marita; Dowdell, Kennichi; Lazzarotto, Cicera R.; Clark, Aaron B.; Notarangelo, Luigi D.; Ravell, Juan C.; Lenardo, Michael J.; Kleinstiver, Benjamin P.; Tsai, Shengdar Q.; Wu, Xiaolin; Dahl, Gary A.; Malech, Harry L.; De Ravin, Suk See
  3. Blood. 2021, Dec 30; 138(26): 2768-2780.
  1. 2.   IL-21 and IFN alpha therapy rescues terminally differentiated NK cells and limits SIV reservoir in ART-treated macaques
  2. Harper, Justin; Huot, Nicolas; Micci, Luca; Tharp, Gregory; King, Colin; Rascle, Philippe; Shenvi, Neeta; Wang, Hong; Galardi, Cristin; Upadhyay, Amit A.; Villinger, Francois; Lifson,Jeffrey; Silvestri, Guido; Easley, Kirk; Jacquelin, Beatrice; Bosinger, Steven; Muller-Trutwin, Michaela; Paiardini, Mirko
  3. Nature communications. 2021, May 17; 12(1):
  1. 3.   Ascorbic Acid Promotes KIR Demethylation during Early NK Cell Differentiation
  2. Wu, Cheng-Ying; Zhang, Bin; Kim, Hansol; Anderson,Steve; Miller, Jeffrey S; Cichocki, Frank
  3. Journal of immunology (Baltimore, Md. : 1950). 2020, SEP 15; 205(6): 1513-1523.
  1. 4.   Minimal PD-1 expression in mouse and human NK cells under diverse conditions
  2. Judge, Sean J.; Dunai, Cordelia; Aguilar, Ethan G.; Vick, Sarah C.; Sturgill, Ian R.; Khuat, Lam T.; Stoffel, Kevin M.; Van Dyke, Jonathan; Longo, Dan L.; Darrow, Morgan A.; Anderson,Steve; Blazar, Bruce R.; Monjazeb, Arta M.; Serody, Jonathan S.; Canter, Robert J.; Murphy, William J.
  3. JOURNAL OF CLINICAL INVESTIGATION. 2020, JUN 1; 130(6): 3051-3068.
  1. 5.   IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion
  2. Conlon, Kevin C.; Potter, E. Lake; Pittaluga, Stefania; Lee, Chyi-Chia Richard; Miljkovic, Milos D.; Fleisher, Thomas A.; Dubois, Sigrid; Bryant, Bonita R.; Petrus, Michael; Perera, Liyanage P.; Hsu, Jennifer; Figg, William D.; Peer, Cody J.; Shih, Joanna H.; Yovandich,Jason; Creekmore,Stephen; Roederer, Mario; Waldmann, Thomas A.
  3. CLINICAL CANCER RESEARCH. 2019, Aug 15; 25(16): 4945-4954.
  1. 6.   Understanding the tumour micro-environment communication network from an NOS2/COX2 perspective
  2. Basudhar,Debashree; Bharadwaj, Gaurav; Somasundaram,Veena; Cheng,Robert; Ridnour,Lisa; Fujita, Mayumi; Lockett,Stephen; Anderson,Steve; McVicar,Daniel; Wink,David
  3. British Journal of Pharmacology. 2019, Jan; 176(2): 155-176.
  1. 7.   HIV-1 Control by NK Cells via Reduced Interaction between KIR2DL2 and HLA-C*12:02/C*14:03
  2. Lin, Zhansong; Kuroki, Kimiko; Kuse, Nozomi; Sun, Xiaoming; Akahoshi, Tomohiro; Qi, Ying; Chikata, Takayuki; Naruto, Takuya; Koyanagi, Madoka; Murakoshi, Hayato; Gatanaga, Hiroyuki; Oka, Shinichi; Carrington, Mary; Maenaka, Katsumi; Takiguchi, Masafumi
  3. CELL REPORTS. 2016, Nov 22; 17(9): 2210-2220.
  1. 8.   Diversity of the KIR gene cluster in an urban Brazilian population
  2. Augusto, D. G.; Zehnder-Alves, L.; Pincerati, M. R.; Martin, M. P.; Carrington, M.; Petzl-Erler, M. L.
  3. Immunogenetics. 2012, Feb; 64(2): 143-152.
  1. 9.   Altered distribution of mucosal NK cells during HIV infection
  2. Sips, M.; Sciaranghella, G.; Diefenbach, T.; Dugast, A. S.; Berger, C. T.; Liu, Q.; Kwon, D.; Ghebremichael, M.; Estes, J. D.; Carrington, M.; Martin, J. N.; Deeks, S. G.; Hunt, P. W.; Alter, G.
  3. Mucosal Immunology. 2012, Jan; 5(1): 30-40.
  1. 10.   Copy Number Variation of KIR Genes Influences HIV-1 Control
  2. Pelak, K.; Need, A. C.; Fellay, J.; Shianna, K. V.; Feng, S.; Urban, T. J.; Ge, D. L.; De Luca, A.; Martinez-Picado, J.; Wolinsky, S. M.; Martinson, J. J.; Jamieson, B. D.; Bream, J. H.; Martin, M. P.; Borrow, P.; Letvin, N. L.; McMichael, A. J.; Haynes, B. F.; Telenti, A.; Carrington, M.; Goldstein, D. B.; Alter, G.; Vaccine, N. C. H. A.
  3. Plos Biology. 2011, Nov; 9(11):
  1. 11.   KIR2DL2 Enhances Protective and Detrimental HLA Class I-Mediated Immunity in Chronic Viral Infection
  2. al Basatena, N. K. S.; MacNamara, A.; Vine, A. M.; Thio, C. L.; Astemborski, J.; Usuku, K.; Osame, M.; Kirk, G. D.; Donfield, S. M.; Goedert, J. J.; Bangham, C. R. M.; Carrington, M.; Khakoo, S. I.; Asquith, B.
  3. Plos Pathogens. 2011, Oct; 7(10): 12.
  1. 12.   Ex vivo functional responses to HLA-G differ between blood and decidual NK cells
  2. Apps, R.; Sharkey, A.; Gardner, L.; Male, V.; Kennedy, P.; Masters, L.; Farrell, L.; Jones, D.; Thomas, R.; Moffett, A.
  3. Molecular Human Reproduction. 2011, Sep; 17(9): 577-586.
  1. 13.   HIV-1 adaptation to NK-cell-mediated immune pressure
  2. Alter, G.; Heckerman, D.; Schneidewind, A.; Fadda, L.; Kadie, C. M.; Carlson, J. M.; Oniangue-Ndza, C.; Martin, M.; Li, B.; Khakoo, S. I.; Carrington, M.; Allen, T. M.; Altfeld, M.
  3. Nature. 2011, Aug; 476(7358): 96-+.
  1. 14.   Mouse Ly49G2(+) NK cells dominate early responses during both immune reconstitution and activation independently of MHC
  2. Barao, I.; Alvarez, M.; Ames, E.; Orr, M. T.; Stefanski, H. E.; Blazar, B. R.; Lanier, L. L.; Anderson, S. K.; Redelman, D.; Murphy, W. J.
  3. Blood. 2011, Jun; 117(26): 7032-7041.
  1. 15.   KIR Polymorphisms Modulate Peptide-Dependent Binding to an MHC Class I Ligand with a Bw6 Motif
  2. Colantonio, A. D.; Bimber, B. N.; Neidermyer, W. J.; Reeves, R. K.; Alter, G.; Altfeld, M.; Johnson, R. P.; Carrington, M.; O'Connor, D. H.; Evans, D. T.
  3. Plos Pathogens. 2011, Mar; 7(3): 13.
  1. 16.   LAB/NTAL/Lat2: a force to be reckoned with in all leukocytes?
  2. Orr, S. J.; McVicar, D. W.
  3. Journal of Leukocyte Biology. 2011, Jan; 89(1): 11-19.
  1. 17.   HLA/KIR Restraint of HIV: Surviving the Fittest
  2. Bashirova, A. A.; Thomas, R.; Carrington, M.; Paul, W. E.; Littman, D. R.; Yokoyama, W. M.
  3. Annual Review of Immunology. 2011 29: 295-317.
  1. 18.   Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?
  2. Shurin, M. R.; Gregory, M.; Morris, J. C.; Malyguine, A. M.
  3. Expert Opinion on Biological Therapy. 2010, Nov; 10(11): 1539-1553.
  1. 19.   Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2
  2. Hiby, S. E.; Apps, R.; Sharkey, A. M.; Farrell, L. E.; Gardner, L.; Mulder, A.; Claas, F. H.; Walker, J. J.; Redman, C. C.; Morgan, L.; Tower, C.; Regan, L.; Moore, G. E.; Carrington, M.; Moffett, A.
  3. Journal of Clinical Investigation. 2010, Nov; 120(11): 4102-4110.
  1. 20.   Emergence of Simian Immunodeficiency Virus-Specific Cytotoxic CD4(+) T Cells and Increased Humoral Responses Correlate with Control of Rebounding Viremia in CD8-Depleted Macaques Infected with Rev-Independent Live-Attenuated Simian Immunodeficiency Virus
  2. von Gegerfelt, A.; Valentin, A.; Alicea, C.; Van Rompay, K. K. A.; Marthas, M. L.; Montefiori, D. C.; Pavlakis, G. N.; Felber, B. K.
  3. Journal of Immunology. 2010, Sep 15; 185(6): 3348-3358.
  1. 21.   Cutting Edge: KIR Antisense Transcripts Are Processed into a 28-Base PIWI-Like RNA in Human NK Cells
  2. Cichocki, F.; Lenvik, T.; Sharma, N.; Yun, G.; Anderson, S. K.; Miller, J. S.
  3. Journal of Immunology. 2010, Aug; 185(4): 2009-2012.
  1. 22.   TLR3 and Rig-Like Receptor on Myeloid Dendritic Cells and Rig-Like Receptor on Human NK Cells Are Both Mandatory for Production of IFN-gamma in Response to Double-Stranded RNA
  2. Perrot, I.; Deauvieau, F.; Massacrier, C.; Hughes, N.; Garrone, P.; Durand, I.; Demaria, O.; Viaud, N.; Gauthier, L.; Blery, M.; Bonnefoy-Berard, N.; Morel, Y.; Tschopp, J.; Alexopoulou, L.; Trinchieri, G.; Paturel, C.; Caux, C.
  3. Journal of Immunology. 2010, Aug; 185(4): 2080-2088.
  1. 23.   Implications for Gene Therapy-Limiting Expression of IL-2R gamma(c) Delineate Differences in Signaling Thresholds Required for Lymphocyte Development and Maintenance
  2. Orr, S. J.; Roessler, S.; Quigley, L.; Chan, T.; Ford, J. W.; O'Connor, G. M.; McVicar, D. W.
  3. Journal of Immunology. 2010, Aug; 185(3): 1393-1403.
  1. 24.   Adaptive control of innate immunity
  2. Shanker, A.
  3. Immunology Letters. 2010, Jul; 131(2): 107-112.
  1. 25.   Modulation of stress genes expression profile by nitric oxide-releasing aspirin in Jurkat T leukemia cells
  2. Nath, N.; Chattopadhyay, M.; Kodela, R.; Tian, S.; Vlismas, P.; Boring, D.; Crowell, J. A.; Kashfi, K.
  3. Biochemical Pharmacology. 2010, Jun; 79(12): 1759-1771.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel